Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 1985 word(s) 1985 2021-09-02 05:12:39 |
2 format correction Meta information modification 1985 2021-09-03 04:45:54 |

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Anagnostis, P. Vitamin D and Infertility. Encyclopedia. Available online: (accessed on 19 April 2024).
Anagnostis P. Vitamin D and Infertility. Encyclopedia. Available at: Accessed April 19, 2024.
Anagnostis, Panagiotis. "Vitamin D and Infertility" Encyclopedia, (accessed April 19, 2024).
Anagnostis, P. (2021, September 02). Vitamin D and Infertility. In Encyclopedia.
Anagnostis, Panagiotis. "Vitamin D and Infertility." Encyclopedia. Web. 02 September, 2021.
Vitamin D and Infertility

Vitamin D plays a crucial role in calcium and phosphate homeostasis, by increasing intestinal calcium absorption and renal calcium reabsorption.  For vitamin D, accumulating evidence from observational human studies suggests a key role for both male and female fertility.

vitamin D infertility assisted reproductive technologies

1. Introduction

Vitamin D plays a crucial role in calcium and phosphate homeostasis, by increasing intestinal calcium absorption and renal calcium reabsorption [1]. It is found in two major forms, D2 (ergocalciferol) and D3 (cholecalciferol). The former is produced by ergosterol upon irradiation in plants and fungi. The latter is produced by 7-dehydrocholesterol upon irradiation in the epidermis [2]. After hydroxylation at carbon 25 [producing 25-hydroxyvitamin D, 25(OH)D], it is transported to the kidney, where it is hydroxylated by 1α-hydroxylase (CYP27B1) at the carbon 1 of the A ring, producing 1,25-dihydroxy-vitamin D [1,25(OH)2D], the active form of vitamin D [3]. CYP27B1 is also present in extrarenal sites, such as macrophages, osteoblasts, epithelial, endocrine, placental and cancer cells [4]. The mechanism of 1,25(OH)2D action involves its binding to vitamin D receptor (VDR), a transcription factor, member of the steroid hormone nuclear receptor family [2]. VDR and CYP27B1 are expressed in various cells, indicating that vitamin D is characterized by a plethora of extra-skeletal actions, such as those on the immune and cardiovascular system [5].
Vitamin D deficiency is defined as 25(OH)D concentrations <20 ng/mL (50 nmol/L), whereas vitamin D insufficiency as 25(OH)D concentrations 20–30 ng/mL (50–75 nmol/L) [6]. The prevalence of vitamin D deficiency ranges from 8 to 90% in Europe (reaching >50% in Western European populations) and from 14 to 89% in North America [7].

2. Vitamin D and Infertility

2.1. Vitamin D and Male Infertility (Observational Studies)

An accumulative body of evidence from observational studies suggests a potentially key role for vitamin D in male reproductive function, including semen quality and androgen status. This is indicated by a positive correlation between vitamin D concentrations and sperm motility [8][9][10] and vitamin D concentrations and normal sperm morphology in infertile men [11]. Particularly, a cross-sectional study including 300 men showed that men with severe vitamin D deficiency [25(OH)D <10 ng/mL] had a lower proportion of motile spermatozoa (62% vs. 70%; p = 0.027), progressive motile spermatozoa (56% vs. 64%; p = 0.035) and % of morphologically normal spermatozoa (6% vs. 8%; p = 0.044) compared with those with vitamin D sufficiency [11]. Similar results were obtained from a subsequent prospective study including 1427 infertile men, which demonstrated higher sperm motility in men with 25(OH)D >30 ng/mL compared with those with 25(OH)D <10 ng/mL [45% (31–63%) vs. 34% (22–54%), respectively; p = 0.030]. However, no differences were observed regarding total sperm count, sperm concentration, sperm volume or sperm morphology [12]. On the other hand, a cross-sectional study, including 170 men, showed a U-shaped correlation of vitamin D concentrations with semen parameters, supporting that not only low, but also high vitamin D concentrations are associated with impaired sperm quality [13]. In detail, men with high vitamin D concentrations (≥50 ng had lower sperm concentration [46.7 (95% confidence interval (CI) 27.2 to 73.9) vs. 84.0 (95% CI 70.3 to 99.3) million/mL; p < 0.05), progressive motile sperm [38.4% (95% CI 29.3 to 49.2) vs. 52.6% (95% CI 47.6 to 58.0); p < 0.05] and normal sperm morphology [18% (95% CI 12.1 to 25.6) vs. 27.4% (95% CI 23.8 to 31.3); p < 0.05) compared with those with 25(OH)D concentrations between 20 and 50 ng/mL [13].
Furthermore, serum 25(OH)D concentrations are associated not only with semen quality, but also with androgen status. Data from cross-sectional studies have shown a positive association between 25(OH)D and testosterone concentrations [14][15][16]. In particular, a large cross-sectional study of 2299 men demonstrated higher total testosterone concentrations, free androgen index, and lower SHBG concentrations in vitamin D-sufficient compared with vitamin D-insufficient or -deficient men (p < 0.05 for all) [15]. Likewise, results from another cross-sectional survey of 3369 men in eight European centers (the European Male Ageing Study) supported a linkage between vitamin D deficiency and secondary or compensated hypogonadism [relative risk ratio (RRR) = 1.16, p = 0.05], as 25(OH)D concentrations were positively associated with total and free testosterone and negatively with estradiol and LH concentrations [16].

2.2. Vitamin D and Male Infertility (Interventional Studies)

Few interventional studies have assessed the effect of vitamin D supplementation on semen quality, male fertility and testosterone concentrations. In a recent triple-blinded, randomized clinical trial, 330 men with infertility and vitamin D insufficiency received either a single dose of 300,000 IU cholecalciferol (followed by 1400 IU/day, combined with calcium 500 mg/day for 150 days) or placebo. Although there was no difference in sperm concentration, the number of spontaneous pregnancies was higher in the vitamin D compared with the placebo group (7.3% vs. 2.4%; 95% CI −0.6% to +10.5%) [17]. In another study, 86 infertile men with idiopathic oligoasthenospermia were randomized to oral cholecalciferol 200 IU/day with calcium 600 mg/day, or a combination of vitamin E 100 mg plus vitamin C 100 mg, t.i.d. After three months, semen quality, especially the progressively motile sperm count per ejaculate and the proportion of progressively motile sperm were increased only in the vitamin D group. In particular, the mean count of progressively motile sperm per ejaculate was increased from 9.8 ± 3.7 × 106 to 21.5 ± 6.5 × 106 (p < 0.05) in the vitamin D group, while it was increased from 9.5 ± 6.3 × 106 to 12.4 ± 4.4 × 106 (p > 0.05) in the control group. The proportion of progressively motile sperm was also increased, from 18.4 ± 9.8% to 28.3 ± 4.5% (p < 0.05) in the vitamin D group, while it did not increase in the control group (17.8 ± 5.3% to 21.4 ± 2.4%; p > 0.05). In addition, pregnancy rates were higher in the vitamin D group (16.3%) compared with the control group (2.3%) (p < 0.05) [18].
Additional interventional studies assessed the association between vitamin D and androgen status. A randomized controlled trial (RCT) in vitamin D-deficient men evaluated the effect of vitamin D supplementation (cholecalciferol 3330 IU/day, n = 31) on testosterone concentrations, compared with placebo (n = 23) [19]. An increase in total (10.7 ± 3.9 to 13.4 ± 4.7 nmol/L; p < 0.001), bioactive (from 5.2 ± 1.9 to 6.3 ± 2.0 nmol/L; p < 0.001) and free testosterone concentrations (from 0.22 ± 0.08 nmol/L to 0.27 ± 0.09 nmol/L; p < 0.001) was observed in the vitamin D supplemented group, while there was no change in the placebo group [19]. Similar results were demonstrated by a prospective study, including 102 men who received a single dose of ergocalciferol (600,000 IU). Significant increase in serum total testosterone concentrations (from 12.46 ± 3.30 to 15.99 ± 1.84 nmol/L, p < 0.01) and erectile function scores (from 13.88 ± 3.96 to 20.25 ± 3.24, p < 0.01) were observed after 12 months [20].
The aforementioned data suggest a potentially adverse effect of low vitamin D status on male fertility, although a U-shape is more representative of its association with infertility. Vitamin D supplementation may improve sperm quality and increase spontaneous pregnancy rates and testosterone concentrations. Thus, while there is no level 1 evidence, vitamin D supplementation, achieving sufficient but not high (i.e., 30–50 ng/mL) 25(OH)D concentrations, may have a beneficial effect on male infertility [21].

2.3. Vitamin D and Female Infertility (Observational Studies)

Recently, research has focused on the role of vitamin D concentrations in women undergoing assisted reproductive technologies (ART). Based on data reported in a systematic review and meta-analysis of 11 cohort studies, including 2700 women, investigating the association between vitamin D status and ART outcome, higher live birth rates have been reported in vitamin D-sufficient compared with vitamin D-deficient and -insufficient women [odds ratio (OR): 1.33 (95% CI 1.08 to 1.65), seven studies] [22]. Similar results were shown in another recently published meta-analysis of nine cohort studies, which supported the decreased live birth rates after in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) in women with vitamin D deficiency compared with those of sufficient vitamin D status [relative risk (RR): 0.74 (95% CI 0.58 to 0.90), three studies] [23].
Vitamin D has also been involved in the development of specific gynecological conditions affecting fertility, such as endometriosis and polycystic ovarian syndrome (PCOS). In particular, a cohort study of 49 women showed a significant linear correlation between 25(OH)D concentrations and the diameter of ovarian endometriomas (r = −0.3, p = 0.03) [24]. Moreover, a prospective comparative study, evaluating 25(OH)D concentrations in 135 women with endometriosis and 90 controls, showed that the incidence of women with vitamin D deficiency/insufficiency was significantly higher in women with endometriosis compared with the control group (80% vs. 33.3%; p < 0.001) [25]. Moreover, the impact of vitamin D concentrations on reproductive outcomes, in women with PCOS undergoing ovulation induction, has been investigated in a retrospective cohort study (n = 540). This study showed that vitamin D-deficient women were less likely to achieve ovulation compared with those with 25(OH)D >20 ng/mL (OR 0.43, 95% CI 0.25 to 0.76, p = 0.006). Furthermore, live birth rates after ovulation induction were increased by 2% for each 1 ng/mL increase in 25(OH)D concentrations (OR 1.02, 95% CI 1.00 to 1.04, p = 0.040) [26]. However, data are still insufficient in order to establish a possible causality between vitamin D and endometriosis or vitamin D and PCOS. Further studies are needed to confirm these associations.

2.4. Vitamin D and Female Infertility (Interventional Studies)

Few RCTs currently exist evaluating the effect of vitamin D supplementation on ART outcome, yielding inconclusive results. In a recent RCT [27], infertile women undergoing ICSI, using both fresh and frozen embryo transfers, were randomized to either cholecalciferol (50,000 IU/week) supplementation for six weeks (n = 42) or placebo (n = 43). Higher clinical pregnancy rates were shown in the vitamin D group compared with the placebo group (38.1% vs. 20.1%, p = 0.019) [27]. On the other hand, another RCT including 128 infertile women with vitamin D insufficiency, who underwent frozen-thawed embryo transfer cycles after IVF/ICSI and were treated either with cholecalciferol (50,000 IU/week) for 6-8 weeks (n = 57) or with no intervention (n = 57) [28], did not show any difference in clinical pregnancy rates between the two groups (25.5% vs. 21.8%, respectively; p = 0.810) [28]. Although safe conclusions cannot be drawn by these two studies [of note, both were conducted in Iran, with baseline 25(OH)D concentrations of 12.7–15.8 ng/mL], one should underline some differences between them, which may have had an impact on this discrepancy. First, participants of the former study [27] were of normal body weight in contrast to those of the latter (mean BMI >26 kg/m2) [28]. Second, the type of fertilization and the method of embryo transfer (i.e., fresh or frozen) also differed between studies. Third, 25(OH)D concentrations achieved after vitamin D supplementation also differed between studies (37 ng [27] vs. 47 ng/mL [28], respectively).
With respect to PCOS patients, there is evidence for a possible beneficial effect of vitamin D supplementation on fertility outcomes. Particularly, a recent meta-analysis of nine RCTs (502 PCOS women) showed that vitamin D supplementation (in different doses) resulted in increased number of dominant follicles (>14 mm) compared with placebo or metformin (1000–1500 mg/day) (OR: 2.34, 95% CI 1.39 to 3.92, four RCTs) [29]. Moreover, the same meta-analysis showed that vitamin D supplementation especially combined with metformin in women with PCOS seems to regulate menstrual cycles compared with women treated with metformin only (OR 1.85, 95% CI 1.01 to 3.39, three RCTs) [29]. In addition, a recent double-blinded RCT was conducted aiming to evaluate the role of vitamin D supplementation on ICSI outcomes in 105 PCOS infertile women. Patients were randomized either to treatment group (vitamin E, 400 mg/day and vitamin D3, 50,000 IU every two weeks, n = 52) or placebo group (n = 53) for eight weeks. A higher clinical pregnancy rate was observed in the treatment group compared with the placebo group (62.1% vs. 22.6%; p = 0.002), suggesting thus a beneficial effect of combined supplementation of vitamin D and E on ICSI outcomes in PCOS patients [30].
Thus, accumulating evidence supports the notion that vitamin D may play an important role in female fertility. Observational studies associate vitamin D status with IVF outcome, endometriosis and reproductive success after ovulation induction in women with PCOS (Table 1). However, RCTs have not yet established the effect of vitamin D supplementation on the success of ART. Hence, while there is no level 1 evidence, vitamin D sufficiency may be required for improving female fertility outcome.
Table 1. Vitamin D and infertility.

Male infertility

Linear or U-shaped correlation between vitamin D concentrations and sperm motility/morphology [8][9][10][11][12][13].

Sufficient vitamin D concentrations associated with high testosterone concentrations [14][15][16].

Supplementation of vitamin D improved semen quality and pregnancy rates [17][18].

Supplementation of vitamin D increased testosterone concentrations [19][20].

Female infertility

Contradictory data on whether supplementation of vitamin D is associated with pregnancy rates [27][28].


Higher live birth rates in vitamin D-sufficient women [22][23].


Linear correlation between vitamin D concentrations and diameter of ovarian endometriomas [24].

Higher incidence of vitamin D deficiency/insufficiency in women with endometriosis [25].


Linear correlation between vitamin D levels and reproductive success rates after ovulation induction in women with PCOS [26].

Abbreviations: ART: assisted reproductive techniques; PCOS: polycystic ovary syndrome.


  1. Lieben, L.; Carmeliet, G.; Masuyama, R. Calcemic actions of vitamin D: Effects on the intestine, kidney and bone. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25, 561–572.
  2. Bikle, D.D. Vitamin D metabolism, mechanism of action, and clinical applications. Chem. Biol. 2014, 21, 319–329.
  3. Christakos, S.; Dhawan, P.; Verstuyf, A.; Verlinden, L.; Carmeliet, G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol. Rev. 2016, 96, 365–408.
  4. Bikle, D.D. Extra Renal Synthesis of 1,25-dihydroxyvitamin D and its Health Implications. Clin. Rev. Bone Miner. Metab. 2009, 7, 114–125.
  5. Bouillon, R.; Marcocci, C.; Carmeliet, G.; Bikle, D.; White, J.H.; Dawson-Hughes, B.; Lips, P.; Munns, C.F.; Lazaretti-Castro, M.; Giustina, A.; et al. Skeletal and extra-skeletal actions of vitamin D: Current evidence and outstanding questions. Endocr. Rev. 2018.
  6. Haimi, M.; Kremer, R. Vitamin D deficiency/insufficiency from childhood to adulthood: Insights from a sunny country. World J. Clin. Pediatr. 2017, 6, 1–9.
  7. Van Schoor, N.; Lips, P. Global Overview of Vitamin D Status. Endocrinol. Metab. Clin. North Am. 2017, 46, 845–870.
  8. Abbasihormozi, S.; Kouhkan, A.; Alizadeh, A.R.; Shahverdi, A.H.; Nasr-Esfahani, M.H.; Sadighi Gilani, M.A.; Salman Yazdi, R.; Matinibehzad, A.; Zolfaghari, Z. Association of vitamin D status with semen quality and reproductive hormones in Iranian subfertile men. Andrology 2017, 5, 113–118.
  9. Tirabassi, G.; Cutini, M.; Muscogiuri, G.; Delli Muti, N.; Corona, G.; Galdiero, M.; Pivonello, R.; Colao, A.; Balercia, G. Association between vitamin D and sperm parameters: Clinical evidence. Endocrine 2017, 58, 194–198.
  10. Zhu, C.L.; Xu, Q.F.; Li, S.X.; Wei, Y.C.; Zhu, G.C.; Yang, C.; Shi, Y.C. Investigation of serum vitamin D levels in Chinese infertile men. Andrologia 2016, 48, 1261–1266.
  11. Blomberg Jensen, M.; Bjerrum, P.J.; Jessen, T.E.; Nielsen, J.E.; Joensen, U.N.; Olesen, I.A.; Petersen, J.H.; Juul, A.; Dissing, S.; Jorgensen, N. Vitamin D is positively associated with sperm motility and increases intracellular calcium in human spermatozoa. Human Reprod. (Oxford, England) 2011, 26, 1307–1317.
  12. Blomberg Jensen, M.; Gerner Lawaetz, J.; Andersson, A.M.; Petersen, J.H.; Nordkap, L.; Bang, A.K.; Ekbom, P.; Joensen, U.N.; Praetorius, L.; Lundstrom, P.; et al. Vitamin D deficiency and low ionized calcium are linked with semen quality and sex steroid levels in infertile men. Human Reprod. (Oxford, England) 2016, 31, 1875–1885.
  13. Hammoud, A.O.; Meikle, A.W.; Peterson, C.M.; Stanford, J.; Gibson, M.; Carrell, D.T. Association of 25-hydroxy-vitamin D levels with semen and hormonal parameters. Asian J. Androl. 2012, 14, 855–859.
  14. Rehman, R.; Lalani, S.; Baig, M.; Nizami, I.; Rana, Z.; Gazzaz, Z.J. Association Between Vitamin D, Reproductive Hormones and Sperm Parameters in Infertile Male Subjects. Front. Endocrinol. (Lausanne) 2018, 9, 607.
  15. Wehr, E.; Pilz, S.; Boehm, B.O.; Marz, W.; Obermayer-Pietsch, B. Association of vitamin D status with serum androgen levels in men. Clin. Endocrinol. (Oxf.) 2010, 73, 243–248.
  16. Lee, D.M.; Tajar, A.; Pye, S.R.; Boonen, S.; Vanderschueren, D.; Bouillon, R.; O’Neill, T.W.; Bartfai, G.; Casanueva, F.F.; Finn, J.D.; et al. Association of hypogonadism with vitamin D status: The European Male Ageing Study. Eur. J. Endocrinol. 2012, 166, 77–85.
  17. Blomberg Jensen, M.; Lawaetz, J.G.; Petersen, J.H.; Juul, A.; Jorgensen, N. Effects of Vitamin D Supplementation on Semen Quality, Reproductive Hormones, and Live Birth Rate: A Randomized Clinical Trial. J. Clin. Endocrinol. Metab. 2018, 103, 870–881.
  18. Deng, X.L.; Li, Y.M.; Yang, X.Y.; Huang, J.R.; Guo, S.L.; Song, L.M. Efficacy and safety of vitamin D in the treatment of idiopathic oligoasthenozoospermia. Zhonghua Nan Ke Xue 2014, 20, 1082–1085.
  19. Pilz, S.; Frisch, S.; Koertke, H.; Kuhn, J.; Dreier, J.; Obermayer-Pietsch, B.; Wehr, E.; Zittermann, A. Effect of vitamin D supplementation on testosterone levels in men. Horm. Metab. Res. 2011, 43, 223–225.
  20. Canguven, O.; Talib, R.A.; El Ansari, W.; Yassin, D.J.; Al Naimi, A. Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. Aging Male 2017, 20, 9–16.
  21. Karras, S.; Anagnostis, P.; Kotsa, K.; Goulis, D.G. Vitamin D and gonadal function in men: A potential inverse U-shaped association? Andrology 2016, 4, 542–544.
  22. Chu, J.; Gallos, I.; Tobias, A.; Tan, B.; Eapen, A.; Coomarasamy, A. Vitamin D and assisted reproductive treatment outcome: A systematic review and meta-analysis. Human Reprod. (Oxford, England) 2018, 33, 65–80.
  23. Zhao, J.; Huang, X.; Xu, B.; Yan, Y.; Zhang, Q.; Li, Y. Whether vitamin D was associated with clinical outcome after IVF/ICSI: A systematic review and meta-analysis. Reprod. Biol. Endocrinol. 2018, 16, 13.
  24. Ciavattini, A.; Serri, M.; Delli Carpini, G.; Morini, S.; Clemente, N. Ovarian endometriosis and vitamin D serum levels. Gynecol. Endocrinol. 2017, 33, 164–167.
  25. Anastasi, E.; Fuggetta, E.; De Vito, C.; Migliara, G.; Viggiani, V.; Manganaro, L.; Granato, T.; Benedetti Panici, P.; Angeloni, A.; Porpora, M.G. Low levels of 25-OH vitamin D in women with endometriosis and associated pelvic pain. Clin. Chem. Lab. Med. 2017, 55, e282–e284.
  26. Pal, L.; Zhang, H.; Williams, J.; Santoro, N.F.; Diamond, M.P.; Schlaff, W.D.; Coutifaris, C.; Carson, S.A.; Steinkampf, M.P.; Carr, B.R.; et al. Vitamin D Status Relates to Reproductive Outcome in Women With Polycystic Ovary Syndrome: Secondary Analysis of a Multicenter Randomized Controlled Trial. J. Clin. Endocrinol. Metab. 2016, 101, 3027–3035.
  27. Abedi, S.; Taebi, M.; Nasr Esfahani, M.H. Effect of Vitamin D Supplementation on Intracytoplasmic Sperm Injection Outcomes: A Randomized Double-Blind Placebo-Controlled Trial. Int. J. Fertil. Steril. 2019, 13, 18–23.
  28. Aflatoonian, A.; Arabjahvani, F.; Eftekhar, M.; Sayadi, M. Effect of vitamin D insufficiency treatment on fertility outcomes in frozen-thawed embryo transfer cycles: A randomized clinical trial. Iran J. Reprod. Med. 2014, 12, 595–600.
  29. Fang, F.; Ni, K.; Cai, Y.; Shang, J.; Zhang, X.; Xiong, C. Effect of vitamin D supplementation on polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Complement Ther. Clin. Pract. 2017, 26, 53–60.
  30. Fatemi, F.; Mohammadzadeh, A.; Sadeghi, M.R.; Akhondi, M.M.; Mohammadmoradi, S.; Kamali, K.; Lackpour, N.; Jouhari, S.; Zafadoust, S.; Mokhtar, S.; et al. Role of vitamin E and D3 supplementation in Intra-Cytoplasmic Sperm Injection outcomes of women with polycystic ovarian syndrome: A double blinded randomized placebo-controlled trial. Clin. Nutr. ESPEN 2017, 18, 23–30.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 450
Revisions: 2 times (View History)
Update Date: 03 Sep 2021